<DOC>
	<DOCNO>NCT02230020</DOCNO>
	<brief_summary>Preliminary data show COPD patient , HFT substantially decrease ventilatory demand sleep . The central hypothesis proposal lower ventilatory demand use nasal high-flow therapy sleep elevate lung function , reduce dyspnea exertion improve quality life . Thus , proposal aim determine effect HFT time 1 ) lung function ; 2 ) dyspnea exertion ; 3 ) quality life .</brief_summary>
	<brief_title>Efficacy High Flow Therapy COPD At Home</brief_title>
	<detailed_description />
	<criteria>1 . Consenting adults age 18 COPD 1 . Apnea Hypopnea Index &gt; 15 events/hr 2 . Use Noninvasive positive pressure ventilation ( CPAP + Bilevel ) 3 . Severe bilateral nasal obstruction ( apparent mouth breathe rest ) 4 . Documented clinical cardiovascular disease , define : 1. myocardial infarction past 3 month 2. revascularization procedure past 3 month 3. implanted cardiac pacemaker ICD 4. unstable arrhythmias 5. congestive heart failure ejection fraction &lt; 40 % 6. uncontrolled hypertension ( BP &gt; 190/110 ) 5 . History end stage renal disease ( dialysis ) 6 . History end stage liver disease , : 1 . Jaundice 2. ascites 3. history recurrent gastrointestinal bleeding 4. transjugular intrahepatic portosystemic shunt ( TIPS ) ; 7 . Transportation industry worker ( commercial truck bus driver , airline pilot ) 8 . Known pregnancy ( self report ) 9 . Known coagulopathy anticoagulant use ( e.g . coumadin ) aspirin . 10 . Do take medication follow reason : 1 . Pain control ( besides NSAIDs ) 2 . Sleep medication 3 . Benzodiazepines 4 . Methadone</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>